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Morphological evidence demonstrates the existence of do- 
paminergic afferent pathways and dopamine (DA)-contain- 
ing neurons in the dorsal raphe nucleus (DRN). In a recent 
report, a DA D,-like receptor-mediated regulation of sero- 
tonin (5-HT) extracellular concentration in DRN has been 
found. Given the existence of somatodendritic 5-HT,, au- 
toreceptors in the DRN, changes of the extracellular con- 
centration of 5-HT in the vicinity of cell bodies and dendrites 
may be relevant for the control of the activity of ascending 
serotonergic pathways. In the present brain microdialysis 
study we have used a chromatographic method (HPLC) en- 
abling the simultaneous measurement of DA, 5-HT, and their 
main metabolites dihydroxyphenylacetic acid (DOPAC) and 
5-hydroxyindoleacetic acid (5-HIAA). The presence of a neu- 
ronal pool of DA within the DRN was revealed by the local 
infusion of amphetamine (10 PM), which significantly in- 
creased the extracellular concentration of both amines. The 
local striatal infusion (10 PM) of the selective DA D,-like 
agonist SKF-38393, the selective DA D,-like agonist quin- 
pirole (LY 171,555), or the nonselective DA agonist apo- 
morphine markedly decreased DA and DOPAC extracellular 
concentrations and failed to modify 5-HT or 5-HIAA in the 
striatum, indicating the lack of terminal (striatal) control of 
5-HT release by dopaminergic transmission. In contrast, the 
systemic administration of apomorphine (2.8 wmol/kg, s.c.) 
significantly increased the extracellular concentration of 5-HT 
in the DRN and decreased it in the striatum. The reduction 
of striatal 5-HT extracellular concentration was prevented 
by the previous administration of the selective 5-HT,, re- 
ceptor antagonist WAY 100135 (17.6 rmol/kg, s.c.), which 
by itself did not change extracellular 5-HT in striatum. These 
results support that dopaminergic neurotransmission inhib- 
its the activity of DRN-striatal neurons by increasing 5-HT 
extracellular concentration in DRN and, consequently, by 
increasing somatodendritic 5-HT,, autoreceptor stimulation 
in this nucleus. 
[Key words: dorsal raphe nucleus, striatom, serotonin, do- 
pamine, dopamine D,-like receptors, dopamine D,-like re- 
ceptors, serotonin 5-HT,, receptors, in vivo microdialysis] 
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The dorsal raphe nucleus (DRN) (B6 and B7 areas of Dahlstrom 
and Fuxe, 1964) is a morphologically well-defined structure of 
the midbrain that contains, by far, the highest number and 
concentration of serotonergic (5HT) cell bodies of the mam- 
malian brain (Wiklund et al., 198 1; Descarries et al., 1982). 
Serotonergic neurons from the dorsal raphe project mainly to 
the basal ganglia, particularly the striatum (dorsal and ventral), 
the substantia nigra (SN), and the ventral tegmental area (VTA) 
(A9 and A10 areas of Dahlstrom and Fuxe, 1964) (Van der 
Kooy and Hattori, 1980; Herve et al., 1987) and to the frontal 
cortex (O’Hearn and Molliver, 1984). These areas are involved 
in the parallel processing of motor function (Alexander and 
Crutcher, 1990) and are the source of and targets for the mes- 
encephalic dopaminergic systems (Bjorklund and Lindvall, 1984). 
These morphological data suggest hat DRN serotonergic neu- 
rons modulate the function of brain dopaminergic systems. In- 
deed, dopamine (DA)-containing structures display moderate 
to high densities of several 5-HT receptor subtypes (5-HT,,,,,, 
5-HT,, 5-HT,) (Pazos and Palacios, 1985; Pazos et al., 1985; 
Waeber et al., 1989, 1990; Hoyer, 1990) and there is functional 
evidence of a 5-HT-mediated regulation of mesencephalic do- 
paminergic systems, both at the somatodendritic (Nedergaard 
et al., 1988; Guan and McBride, 1989) and at the terminal level 
(Blandina et al., 1989; Benloucif and Galloway, 1991; Chen et 
al., 1991; Parsons and Justice, 1993). 
Less is known, however, about a possible dopaminergic reg- 
ulation of serotonergic DRN neurons, despite morphological 
evidence indicating the existence of projections from SN and 
VTA to the DRN (Afifi and Kaelber, 1965; Pasquier et al., 1977; 
Sakai et al., 1977; Lee and Geyer, 1984; KalCn et al., 1988) and 
of DA-containing neurons within the DRN (Hokfelt et al., 1976; 
Geffard et al., 1987; KalCn et al., 1988). Also, the DRN contains 
a fairly high density of DA D,-like but not of DA D,-like re- 
ceptors (Bouthenet et al., 1987; Palacios and Pazos, 1987). Fur- 
thermore, electrophysiological studies have shown that the elec- 
trical stimulation of SN induces cessation of firing of DRN 
neurons (Stern et al., 1981; for review, see Aghajanian et al., 
1987; Jacobs and Azmitia, 1992). 
The study of the complex interrelationships between both 
aminergic systems is relevant for understanding the serotonergic 
changes occurring in neurological diseases where DA is the 
transmitter primarily involved (e.g., Parkinson’s disease) (Scat- 
ton et al., 1984; Cross, 1988). Besides, DA-5-HT interactions 
are thought to play a role in the mechanism of action of atypical 
neuroleptics (Tamminga and Gerlach, 1987; Meltzer, 1992) and 
dopaminergic transmission appears to participate in the 3,4- 
methylenedioxyamphetamine (MDMA)-induced degeneration 
of serotonergic terminals (see McKenna and Peroutka, 1990, 
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Figure 2. HPLC trace of a basal (predrug) striatal dialysate sample 
showing the presence of DA, DOPAC. S-HT, and 5-HIAA. Absolute 
amounts of these compounds in this sample (I 5 11) of DA, DOPAC, 
5-HT, and 5-HIAA were (in fmol) 175, 185,225, 16, and 22.560, re- 
spectively. 
for review). Using the microdialysis technique, we recently found 
a DA D,-like receptor-mediated regulation of 5-HT extracel- 
lular concentration in the DRN of unanesthetized rats. Local 
infusion of the nonselective DA receptor agonist apomorphine 
or the selective DA D,-like receptor agonist quinpirole induced 
an increase of extracellular 5-HT in the DRN that was antag- 
onized by the DA D,-like receptor antagonist raclopride, but 
not by the DA D,-like antagonist SCH 23390 (Ferre and Artigas, 
1993). The existence of somatodendritic S-HT,, autoreceptors 
that inhibit electrical activity (Sprouse and Aghajanian, 1987, 
1988) S-HT synthesis (Hjorth and Magnusson, 1988; Hutson 
et al., 1989; Invernizzi et al., I99 I), and 5-HT release in pro- 
jection areas (Hutson et al., 1989; Sharp et al.. 1989a; Bonvento 
et al., 1992; Adell et al., 1993) is well documented (Pazos and 
Palacios, 1985: Verge et al., 1986; Sotelo et al., 1990). Therefore, 
an increased dopaminergic transmission within the DRN may 
inhibit the activity of ascending DRN serotonergic neurons 
through an enhancement of 5-HT extracellular concentration in 
DRN and further activation of 5-HT,, autoreceptors. Indeed, 
pharmacologically induced increases of extracellular 5-HT in 
the raphe nuclei reduce terminal 5-HT synthesis and/or release, 
as measured with the push-pull cannula in the cat (Becquet et 
al., 1990) or in riro microdialysis in awake, freely moving rats 
(Adell and Artigas, I99 I). 
In the present study, we have examined the effects of dopa- 
minergic agents on extracellular 5-HT in the DRN and DA and 
5-HT in the striatum. The data obtained support the view that 
+ 
Fl.igLlrc I. Location of the dialysis probes. .4. Photomicrograph from a 
cresyl violet-stained section through the DRN (urea delirnmd b.v dots) 
showing the track left by the microdialysis probe. The schetnatrcdruwing 
ofthc probe represents its actual size and position. The dialysis mem- 
brane corresponds to the part between arrowheuds and the crosshatched 
urea is the tip of the probe (epoxy resin). B, Dark-held photomicrograph 
from an autoradiogram of the DRN at a level similar to that in A. 
Serotonergic ell bodies have been labeled with a “S-oligonucleotide 
directed against he 5-HT transporter mRNA by rn srtu hybridization 
as described elsewhere (Cartes et al., 1993). C, Section through the 
striatum showing the track left by the microdialysis membrane (arrow). 
Scale bar: 250 wrn for A and B, I mm for C. 
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an increased dopaminergic activity results in opposite changes 
of extracellular 5-HT in DRN and striatum. 
Materials and Methods 
.4nima/s. Male Wistar rats weighing 290-3 10 gm were used. They were 
housed four per cage and kept in a controlled environment (I 2 hr light/ 
dark cycle and 22 * 2°C room temperature). Food and water were 
provided ad libitum. Animal care followed the Spanish legislation on 
“Protection ofAnimals Used in Experimental and Other Scientific Pur- 
poses,” in agreement with the European (E.E.C.) regulations (O.J. of 
E.C. L358/1 18/12/1986). 
Surgery. Concentric dialysis probes were made as previously de- 
scribed (Adell and Artigas, 1991), with the exception that the length of 
the membrane exposed to the brain tissue was either I.5 mm or 4.0 
mm long (0.25 mm o.d.). Before implantation, rats were anesthetized 
with so&urn pentobarbital (60 mg/kg, i.p.) and placed in a stereotaxic 
frame. Dialvsis probes (I.5 mm) were implanted in the DRN with a 
lateral angle of i@ and ihe following coordinates, in millimeters, with 
respect to bregma: AP -7.8, L 3. I, D -7.5 (Paxinos and Watson, 1982). 
Dialysis (4 mm) probes were implanted in the striatum with the fol- 
lowing coordinates, in millimeters, with respect to bregma: AP 0.2, L 
3.0, D -8.0 (Paxinos and Watson, 1982). The location of the dialysis 
probes is shown in Figure I. 
Microdialvsis procedure. Animals were allowed to recover from sur- 
gery for approximately 18-20 hr and then probes were perfused with 
artificial cerebrosoinal fluid (125 mM NaCI. 2.5 mM KCI, 1.26 mM 
CaCI,, and I.18 AM MgCI,; PH 6.2) at 0.5 pl/min using a CMA/lOO 
microinjection pump (Carnegie Medicin, Stockholm, Sweden). Sample 
collection started 60 min after the beginning of perfusion. Usually four 
or five basal fractions were collected to obtain basal values before either 
local infusion or systemic administration of drugs. Local administration 
was performed by reverse dialysis. dissolving the appropriate amounts 
of each drug in the perfusion fluid. Systemic administrations were car- 
ried out subcutaneously using 5.5% glucose as vehicle (injection volume 
of 2 ml/kg). The effects of systemic apomorphine on extracellular 5-HT 
in DRN and striatum were performed in separate groups of rats. Given 
the small size of the I .5 mm dialysis probes, citalopram (I FM) was 
added to the artificial CSF to increase the detectability of serotonin 
when probes were implanted within the DRN. Successive 30 min (I 5 
~1) dialysate samples were collected. At the end of the experiment, the 
probe placement was verified by injection of methylene blue and visual 
inspection. Animals with a placement of the probe outside the DRN 
[indicated also by a low extracellular 5-hydroxyindoleacetic acid (5- 
HIAA) concentration; see Discussion] were discarded. The in vitro per- 
centage recoveries of the 1.5 mm dialysis probes for DA, dihydroxy- 
phenylacetic acid (DOPAC), 5-HT, and 5-HIAA were, respectively(flow 
rate = 0.5 pl/min), 20.1 -t 0.9, 21.9 -C 0.6, 23.8 i 1.8, and 18.3 + 0.8 
(n = 4, mean + SEM). For the 4.0 mm dialysis probes these figures 
were, resnectivelv, 50.6 f  1.4. 42.2 + 1.2, 44.7 f  0.9, and 38.7 f  0.5 
(n = 4, mean -f SEM). 
Drugsandreagents. Apomorphine, 5-HT, 5-HIAA, DA, and DOPAC 
were from Siama (St. Louis. MO). Ouinpirole I(-)LY I7 I,5551 and 
(k)SKF-38392 we&from RBI (Naiick; MA). d-Amphetamine was-from 
the Service of Psychotropic Substances, Ministry of Health, Madrid, 
Spain. Other materials and reagents were from local commercial sources. 
Chromatographic ana/.vsis. DA, DOPAC, 5-HT. and 5-HIAA were 
analyzed by a modification of the HPLC method described in Adell 
and Artigas (I 99 I). The composition of HPLC eluent was as follows: 
0. I5 M NaH,PO,. 0.46 mM octyl sodium sulfate, 0.5 mM EDTA (pH 
2.8 adjusted with phosphoric acid), and 18% methanol. The cathecol 
and indole compounds were separated on a 3 Km ODS 2 column (7.5 
cm x 0.46 cm; Beckman. CA) and detected amperometrically with a 
Hewlett Packard 1049 detector, with a limit of detection of 0.5-l fmol 
for standard DA and 5-HT (Fig. 2). This HPLC method enabled the 
simultaneous detection of DA, 5-HT. and their acidic metabolites in 
the Same dialysate samples. 
Data an&is. In each experiment, the results (expressed as means f  
SEM) are given as percentage of basal values. The statistical analysis 
-  
used was the “summary measures” method (Matthews et al., 1990), 
using the mean of the four values previous to drug administration and 
the mean ofthe five values subsequent to drug administration per animal 
as the summary measures. Post- versus predrug values were compared 
using Student’s paired t  test to analyze drug effects. p values refer in all 
cases to these differences. 
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Figure 3. Effect of the intra-DRN infusion of amphetamine (IO pmol/ 
liter) on extracellular concentrations of DA and 5-HT in the DRN. Data 
are mean ir SEM values (n = 4 in both cases) and are given as percentages 
ofbaseline values, determined from the mean ofthe two values previous 
to drug infusion. The horizontal Ilne indicates the period of drug in- 
fusion. 
Results 
Basal dialysate concentrations of DA and 5-HT from the DRN 
(in the presence of 1 kmol/liter citalopram). taken as the mean 
ofthe two values preceding drug administration, were as follows 
(without adjusting for recovery): 1.4 + 0.1 nmol/liter for DA 
and 9.8 ? 2.2 nmol/liter for 5-HT (mean k SEM; n = 4 and 9 
rats, respectively). Basal dialysate concentrations of DA, DO- 
PAC, 5-HT, and 5-HIAA from the striatum, taken as above, 
were (without adjusting for recovery) 15.9 ? 2.9 nmol/liter for 
DA, 16,429 ? 2136 nmol/liter for DOPAC, 1.2 t- 0.2 nmol/ 
liter for 5-HT, and 1309 t 17 1 nmol/liter for 5-HIAA (mean 
-t SEM: IV = 12-25 rats). The occurrence of a neuronal pool of 
DA within the DRN was revealed by the local infusion of 10 
wmol/liter amphetamine. This treatment enhanced DA and 5-HT 
extracellular concentrations (maximal increases +64% and 
+42%; Student’s paired t test: p < 0.01 and p < 0.05, respec- 
tively) (Fig. 3). 
Continuous local infusion of 10 pmol/liter of the nonselective 
DA agonist apomorphine (Fig. 4), the selective DA D,-like ag- 
onist SKF-38393 (Fig. 5), or the selective DA D,-like agonist 
LY- 17 1555 (quinpirole) (Fig. 6) induced a significant decrease 
in the striatal extracellular concentrations of DA (maximal re- 
ductions: - 76%, - 54%, and - 62%, respectively; Student’s 
paired t test, p < 0.01 in all cases) and DOPAC (up to -3O%, 
-32%, and -43%; Student’s paired t test, p < 0.05 for apo- 
morphine effect and p < 0.01 for SKF-38393 and quinpirole 
effects). Neither apomorphine, SKF-38393, nor quinpirole sig- 
nificantly altered the striatal extracellular concentrations of 5-HT 
or 5-HIAA when given locally. 
The systemic administration of apomorphine (2.8 Fmol/kg, 
s.c.) induced a significant increase of DRN 5-HT extracellular 
concentration (maximal increase +75%; Student’s paired t test, 
p < 0.0 I) and a significant decrease of 5-HT extracellular con- 
centration in the striatum (up to -34%; Student’s paired t test, 
JJ < 0.01) (Fig. 7). In the same dialysate samples, DA concen- 
trations decreased to about 40% of basal values in the striatum 
and to undetectable levels in most DRN samples. 
To examine the involvement of 5-HT,, somatodendritic au- 
toreceptors in these opposite changes of extracellular 5-HT in 
DRN and striatum, we used WAY 100135, a selective antag- 
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Figure 4. Effect of intrastriatal infusion of the nonselective DA agonist 
apomorphine (10 rmol/liter) on extracellular concentrations of DA, 
DOPAC, S-HT, and S-HIAA in the striatum. Data are mean + SEM 
values (n = 4) and are given as percentages of baseline values, deter- 
mined from the mean of the two values previous to drug infusion. The 
horizontal line indicates the period of drug infusion. 
Figure 6. Effect of intrastriatal infusion of the selective DA Dz agonist ltrastriatal 
LY- 17 155.5 (quinpirole) (10 pmol/liter) on extracellular concentrations ‘le) 0 ol/liter)  trace lular ncen rations 
of DA, DOPAC, S-HT, and .5-HIAA in the striatum. Data are mean ~fr , nd 
SEM values (n = 4) and are given as percentages of baseline values, 
determined from the mean of the two values previous to drug infusion. llvLll L1lb 
The horizontal line indicates the period of drug infusion. .-’ I’--- ‘ldicates 
onist of 5-HT,, pre- (somatodendritic) and postsynaptic recep- 
tors (Fletcher et al., 1993; Routledge et al., 1993). The treatment 
with WAY 100 135 alone (17.6 kmol/kg, s.c.) did not alter di- 
alysate 5-HT or 5-HIAA in the striatum; yet the systemic (sub- 
cutaneous) pretreatment with WAY 100 135 prevented the re- 
duction of striatal dialysate 5-HT elicited by apomorphine (Fig. 
0 
No overt behavioral effects were observed during local in- 
fusion of the different DA agonists, either in the DRN or in the 
striatum, or after systemic administration of WAY 100135. 
Stereotypies (mainly sniffing and licking) were observed after 
systemic administration of apomorphine and were not modified 
by the previous administration of WAY 100 135. 
Discussion 
Owing to the development of a new HPLC procedure, we have 
been able to determine low (0.5-l fmol) amounts of 5-HT and 
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DA in the same dialysate samples from the DRN and striatum. 
This enabled the simultaneous study of both amines in the same 
animal. The HPLC method devised is particularly useful for the 
analysis of DA and 5-HT at very low concentrations, given their 
short retention times and the consequent increase in detect- 
ability. The present results demonstrate for the first time the 
occurrence of a measurable extracellular concentration of DA 
in the DRN. The somatodendritic or terminal origin of this DA 
is unclear, since both dopaminergic terminals from the SN or 
VTA (Afifi and Kaelber, 1965; Pasquier et al., 1977; Sakai et 
al., 1977; Lee and Geyer, 1984; Kaltn et al., 1988) and DA- 
containing neurons within the DRN (HGkfelt et al., 1976; Gef- 
fard et al., 1987; KalCn et al., 1988) have been described. The 
present results cannot clarify this issue, since amphetamine re- 
leases both terminal and somatodendritic DA (Kalivas and Duf- 
fy, 1991; Robertson et al., 1991). In any case, the increased 
extracellular DA after the local administration of amphetamine 
indicates the existence of a releasable pool of DA close to se- 
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Figure 5. Effect of intrastriatal infusion of the selective DA D,-like Figure 7. Effect of systemic administration of the nonselective DA 
agonist SKF-38393 (10 PmoVliter) on extracellular concentrations of agonist apomorphine (upa) (2.8 pmol/kg) on extracellular concentration 
DA, DOPAC, 5-HT, and 5-HIAA in the striatum. Data are mean ? of 5-HT in the DRN and in the striatum. Data are mean + SEM values 
SEM values (n = 4) and are given as percentages of baseline values, (n = 5 in both cases) and are given as percentages of baseline values, 
determined from the mean of the two values previous to drug infusion. determined from the mean of the two values previous to drug infusion. 
The horizontal line indicates the period of drug infusion. The arrow indicates the time of apomorphine injection. 
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Figure 8. Effect of systemic administration of the 5-HT,, autoreceptor 
antaeonist WAY 100 135 (IV.4 I’) (17.6 umollka. s.c.) alone and together 
with-the nonselective DA agonist apomorphine(apd) (2.8 pmol/kg, s.c.) 
on the extracellular concentration of 5-HT in the striatum. Data are 
mean f  SEM values (n = 4 in both cases) and are given as percentages 
ofbaseline values, determined from the mean ofthe two values previous 
to apomorphine administration. The arrows indicate the times of drug 
administration. 
rotonergic cell bodies and dendrites in the DRN, a nucleus that 
contains a substantial density of DA D,-like receptors (Bouth- 
enet et al., 1987; Palacios and Pazos, 1987). This suggests that 
the DA-5-HT interaction found within the DRN in this and a 
previous study (FerrC and Artigas, 1993) may be physiologically 
relevant for the control of ascending serotonergic pathways. 
5-HT extracellular concentration was also increased by the local 
application of amphetamine in the DRN. This is in accordance 
with data in the literature indicating an in viva releasing action 
ofamphetamine on 5-HT, as meas&d by microdialysis (Parada 
et al., 1988) although an indirect action caused by the increased 
DA may also contribute. 
The basal concentration of extracellular 5-HT was not de- 
pendent on a precise position of the probe in the DRN, as 
observed in rats with an incorrect placement (not included in 
the study). In contrast, a high extracellular 5-HIAA concentra- 
tion was a good indicator of the location of the probe within 
the boundaries ofthe DRN. This agrees with data showing that 
the basal extracellular concentration of 5-HT, as measured with 
microdialysis, is independent to a large extent on the density of 
innervation, thus reflecting the equilibrium between release and 
reuptake (Adell et al., 199 1; Jackson and Abercrombie, 1992). 
However, since 5-HIAA lacks any reuptake system, its extra- 
cellular concentration is determined by its tissue content, higher 
in the raphe nuclei than in other brain areas (Adell et al., 199 1). 
The results obtained in this study extend previous observa- 
tions indicating that (1) dopaminergic transmission increases 
extracellular 5-HT in the DRN, presumably through Dz-like 
receptors (Ferre and Artigas, 1993) and (2) the increased avail- 
ability of 5-HT at somatodendritic 5-HT,, autoreceptors results 
in decreases of terminal serotonergic release (Becquet et al., 
1990; Adell and Artigas, 199 1). 
In agreement with data in the literature, the striatal appli- 
cation of dopaminergic agonists induced a marked decrease of 
DA extracellular concentration. Thus, the local infusion of 10 
pmol/liter of the nonselective DA receptor agonist apomor- 
phine, the selective DA D,-like receptor agonist SKF-38393, or 
the selective DA D,-like receptor agonist quinpirole induced a 
strong and sustained decrease of striatal DA extracellular con- 
centration. Similarly, DOPAC extracellular concentrations were 
significantly decreased by the local infusion of DA agonists. 
These reductions are most probably due to the activation of Dz- 
like release-inhibiting autoreceptors (by apomorphine and quin- 
pirole) or postsynaptic D, -like receptors (by apomorphine and 
SKF 38393) located in striatonigral GABA neurons that control 
the activity ofnigrostriatal dopaminergic neurons (Imperato and 
Di Chiara, 1988; Reid et al., 1990; Fuxe et al., 1992). 
In contrast, striatal 5-HT and 5-HIAA extracellular concen- 
trations in the same animals were unchanged after a dose (10 
pmol/liter) of apomorphine and quinpirole that increased 5-HT 
concentration in DRN (FerrC and Artigas, 1993). Hence, where- 
as 5-HT promotes DA striatal release when applied locally 
(Blandina et al., 1989; Benloucif and Galloway, 1991) the ac- 
tivation of dopaminergic D,-like and Dz-like receptors in the 
striatum does not result in local changes of 5-HT release. Clear- 
ly, this indicates an interaction of serotonergic transmission on 
terminal (striatal) dopaminergic function but not the opposite. 
Yet the local and systemic administration (this study) of the DA 
agonist apomorphine increased raphe extracellular 5-HT, an 
effect mediated by D,-like receptors in the DRN (FerrC and 
Artigas, 1993). An increased intra- and extracellular concentra- 
tion of 5-HT in DRN, as measured by a histofluorescence meth- 
od, has already been reported after the systemic treatment with 
apomorphine (Lee and Geyer, 1984). However, these authors 
described a 1:3 ratio for extra- versus intracellular 5-HT, where- 
as it is widely accepted that this ratio is over 1: 1000 for most 
neurotransmitters (Westerink et al., 1987) in different brain ar- 
eas, including 5-HT in the raphe nuclei (Adell et al., 1991). 
Therefore, the relationship of the present in vivo results with 
the increased extracellular histofluorescence found by these au- 
thors is unclear. Also, apomorphine was reported to increase 
slightly (+ 12%) the striatal (but not the hippocampal) total tis- 
sue content of 5-HT (Lee, 1987) whereas a reduction of striatal 
extracellular 5-HT has been found herein. This discrepancy is 
likely to be due to the measurement of active (extracellular) and 
reserve (intracellular) pools when total tissue concentrations are 
involved. In contrast, only active pools of the transmitter are 
measured with the microdialysis technique. 
The opposite changes ofextracellular 5-HT in DRN (increase) 
and striatum (decrease) induced by the systemic administration 
of apomorphine suggest that DA may inhibit the activity of 
ascending serotonergic pathways originating in the DRN via an 
increase of the extracellular concentration of 5-HT in DRN. 
Presumably, the reduction of striatal extracellular 5-HT results 
from the activation ofsomatodendritic 5-HT,, receptors located 
in DRN (Pazos and Palacios, 1985; Verge et al., 1986; Sotelo 
et al., 1990) secondary to the increase of 5-HT induced by 
apomorphine. Extracellular concentration of 5-HT in the mid- 
brain raphe region is in the low nanomole/liter range (Adell et 
al., 1993) close to its affinity for 5-HT,, receptors (Pedigo et 
al., 198 1). Hence, increases of 5-HT availability in the vicinity 
of serotonergic cell bodies and dendrites may result in decreased 
terminal synthesis and/or release, as shown previously (Becquet 
et al., 1990; Adell and Artigas, 1991). Interestingly, the reduc- 
tion of striatal extracellular 5-HT appears to be delayed with 
respect to the increase produced in DRN. This seems to be at 
variance with the fact that terminal 5-HT release increases hort- 
ly after the electric stimulation of the DRN (Sharp et al., 1989b, 
1990), indicating a firing-coupled release. However, the maxi- 
mal reductions of terminal 5-HT output in frontal cortex or 
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striatum, two areas receiving a prominent DRN innervation, 
after the local (intraraphe) application of direct (S-OH-DPAT; 
Bonvento et al., 1992) and indirect (clomipramine; Adell and 
Artigas, 199 1) 5-HT, agonists are delayed with respect to the 
drug application. This delay has also been observed by Becquet 
et al. (1990). These authors found a decreased 7H-5-HT release 
(newly synthesized from superfused 7H-tryptophan) in the cau- 
date of cats during the perfusion of a 5-HT-releasing agent in 
the DRN. The reduced ?H-5-HT release in striatum persisted 
at least for 1 hr after the withdrawal of the 5-HT-releasing agent 
in DRN, a time when 5-HT release in DRN had almost regained 
normal levels. This is indicative that the diminished 5-HT ter- 
minal release may not be an immediate consequence of the 
suppression of firing at the somatodendritic level by 5-HT or 
5-HT,, agonists (Blier et al., 1987; Sprouse and Aghajanian, 
1987; Sinton and Fallon, 1988) and points toward a reduction 
of a terminal 5-HT releasable pool as a likely cause of the de- 
creased 5-HT extracellular concentration in terminal areas. In- 
deed, 5-HT,, agonists markedly reduce terminal 5-HT synthesis 
when applied locally in the DRN (Hutson et al., 1989; Invernizzi 
et al., 199 l), the striatum and prefrontal cortex being the two 
most sensitive brain areas (Invernizzi et al., 199 1). 
That the reduction of extracellular 5-HT in the striatum fol- 
lowing systemic administration of apomorphine may be sec- 
ondary to the increase of 5-HT in the DRN is also supported 
by the lack of a local action of the dopaminergic agonists (see 
Figs. 4-6) and the blockade of the effect with the systemic treat- 
ment with WAY 100135, a selective antagonist of pre- (so- 
matodendritic) and postsynaptic 5-HT,, receptors (Fletcher et 
al., 1993; Routledge et al.. 1993). At the dose used (17.6 pmol/ 
kg), this compound prevents the reduction of hippocampal5-HT 
release induced by the occupation of somatodendritic 5-HT,, 
receptors by the selective agonist &OH-DPAT (Routledge et 
al., 1993; Romero et al., unpublished observations). The injec- 
tion of WAY 100135 alone did not modify the basal 5-HT 
output in striatum. This agrees with previous reports indicating 
that 5-HT,, autoreceptors in the DRN are not tonically acti- 
vated (Innis and Aghajanian, 1987; Trulson and Frederickson, 
1987; Becquet et al., 1990). 
Interestingly, Stern et al. (198 1) found an almost complete 
suppression of unit activity in DRN following electrical stim- 
ulation of the substantia nigra that, unlike that obtained by 
stimulation of the lateral habenula, could not be blocked by 
picrotoxin. This indicates the existence ofa functional inhibitory 
nigro-raphe pathway not involving GABAergic interneurons in 
the DRN. The results obtained in the present and previous 
(FerrC and Artigas, 1993) studies support the view that the excess 
5-HT in the interstitial space in the DRN after dopaminergic 
D,-like activation may participate in the suppression of unit 
activity found previously (Stern et al., 1981), through the hy- 
perpolarization of serotonergic cells mediated by the opening 
of 5-HT,,-gated K+ channels (Innis and Aghajanian, 1987; Haj- 
Dahmane et al., 199 1). 
In summary, the present results provide neurochemical sup- 
port for an inhibitory dopaminergic control of ascending sero- 
tonergic pathways, mediated at the somatodendritic level (in 
DRN) through increases of the extracellular 5-HT concentra- 
tion. The lack ofa local action ofdopaminergic agents precludes 
a DA-mediated control of striatal 5-HT release at the terminal 
level. The origin of the dopaminergic afferents responsible for 
these effects is uncertain and must await further studies. 
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